Colorectal cancer commonly metastasizes. The liver is the most frequent site of metastases and dominates the length of survival for this disease. As surgical and systemic therapies …
Colorectal cancer (CRC) is the third most common cancer worldwide, with 1.1 million new cases per year, and is the second leading cause of cancer death. 1 CRC occurs more …
E Van Cutsem, A Cervantes, R Adam, A Sobrero… - Annals of …, 2016 - Elsevier
Colorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last decade in particular, the clinical outcome for patients with …
EJ Kuipers, WM Grady, D Lieberman… - Nature reviews …, 2015 - pmc.ncbi.nlm.nih.gov
Colorectal cancer had a low incidence several decades ago. However, it has become a predominant cancer and now accounts for approximately 10% of cancer-related mortality in …
CF Dietrich, T Lorentzen, L Appelbaum… - Ultraschall in der …, 2016 - thieme-connect.com
The third part of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines on Interventional Ultrasound (INVUS) assesses the evidence …
LM Pak, NE Kemeny, M Capanu… - Journal of surgical …, 2018 - Wiley Online Library
Background/Objectives Combination hepatic artery infusion (HAI) and systemic (SYS) chemotherapy for unresectable CRLM results in high tumor‐response rates. This study …
CF Dietrich, T Lorentzen, L Appelbaum… - Ultraschall in der …, 2016 - thieme-connect.com
The third part of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines on Interventional Ultrasound assesses the evidence for …
E Gasser, E Braunwarth, M Riedmann, B Cardini… - PLoS …, 2019 - journals.plos.org
Background Colorectal cancer (CRC) represents a major cause for cancer death and every third patient develops liver metastases (CRLM). Several factors including number and size …
S Evrard, G Torzilli, C Caballero… - European Journal of …, 2018 - Elsevier
The treatment of advanced colorectal liver metastases (CRLMs) follows the biphasic pattern characteristic of oncological surgery. A phase of escalation—the therapeutic aggressiveness …